Table 1 Demographic and clinical characteristics in patients with BD and HCs
|  | Patients with BD (n = 37) | HCs (n = 37) | χ2 or F | P |
|---|---|---|---|---|
Gender (male/female) | 15/22 | 15/22 | 0.00 | 1.00 |
Age (years) | 29.78 ± 10.05 | 29.95 ± 9.02 | 0.01 | 0.94 |
Education (years) | 10.14 ± 2.98 | 11.35 ± 2.36 | 3.78 | 0.06 |
BMI (kg/m2) | 22.94 ± 3.97 | 21.86 ± 2.84 | 1.80 | 0.18 |
Age of illness onset (years) | 21.41 ± 7.62 |  |  |  |
Duration of illness (months) | 107.62 ± 101.94 |  |  |  |
Number of episodes | 4.84 ± 1.48 |  |  |  |
Number of hospitalizations | 3.08 ± 2.88 |  |  |  |
Chlorpromazine equivalents (mg/day) | 189.13 ± 222.19 |  |  |  |
BRMS | 7.04 ± 6.88 (range 0–4) |  |  |  |
HAMD | 13.97 ± 10.24 (range 0–4) |  |  |  |
Frequently used MS | ||||
 Valproate | 30 (81.10%) |  |  |  |
 Lithium | 3 (8.10%) |  |  |  |
 Not taking MS | 4 (10.80%) |  |  |  |